Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/34862
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | GADGEEL, S. M. | |
dc.contributor.author | MOK, T. S. K. | |
dc.contributor.author | PETERS, S. | |
dc.contributor.author | ALEXANDER, J. A. A. | |
dc.contributor.author | LEIGHL, N. B. | |
dc.contributor.author | SRIURANPONG, V. | |
dc.contributor.author | PEROL, M. | |
dc.contributor.author | CASTRO JR., G. De | |
dc.contributor.author | NADAL, E. | |
dc.contributor.author | MARINIS, F. De | |
dc.contributor.author | HAN, J-Y. | |
dc.contributor.author | YAN, M. | |
dc.contributor.author | RIEHL, T. | |
dc.contributor.author | SCHLEIFMAN, E. | |
dc.contributor.author | PAUL, S. M. | |
dc.contributor.author | MOCCI, S. | |
dc.contributor.author | SHAMES, D. | |
dc.contributor.author | MATHISEN, M. S. | |
dc.contributor.author | DZIADZIUSZKO, R. | |
dc.date.accessioned | 2020-02-03T17:21:23Z | - |
dc.date.available | 2020-02-03T17:21:23Z | - |
dc.date.issued | 2019 | |
dc.identifier.citation | ANNALS OF ONCOLOGY, v.30, suppl.5, p.918-918, 2019 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/34862 | - |
dc.description.sponsorship | F. Hoffman-La Roche Ltd. | |
dc.language.iso | eng | |
dc.publisher | OXFORD UNIV PRESS | eng |
dc.relation.ispartof | Annals of Oncology | |
dc.rights | restrictedAccess | eng |
dc.title | Phase II/III blood first assay screening trial (BFAST) in patients (pts) with treatment-naive NSCLC: Initial results from the ALK plus cohort | eng |
dc.type | conferenceObject | eng |
dc.rights.holder | Copyright OXFORD UNIV PRESS | eng |
dc.description.conferencedate | SEP 27-OCT 01, 2019 | |
dc.description.conferencelocal | Barcelona, SPAIN | |
dc.description.conferencename | 44th Congress of the European-Society-for-Medical-Oncology (ESMO) | |
dc.subject.wos | Oncology | eng |
dc.type.category | meeting abstract | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.author.external | GADGEEL, S. M.:Univ Michigan, Dept Internal Med, Rogel Canc Ctr, Ann Arbor, MI 48109 USA | |
hcfmusp.author.external | MOK, T. S. K.:Chinese Univ Hong Kong, State Key Lab Translat Oncol, Hong Kong, Peoples R China | |
hcfmusp.author.external | PETERS, S.:Univ Hosp Vaudois CHUV, Multidisciplinary Oncol Ctr, Lausanne, Switzerland | |
hcfmusp.author.external | ALEXANDER, J. A. A.:Hlth Pharma Profess Res, Clin Oncol Toracia, New Mexico, Mexico | |
hcfmusp.author.external | LEIGHL, N. B.:Princess Margaret Canc Ctr, CCRU, Toronto, ON, Canada | |
hcfmusp.author.external | SRIURANPONG, V.:King Chulalongkorn Mem Hosp, Med Oncol Unit, Bangkok, Thailand | |
hcfmusp.author.external | PEROL, M.:Leon Berard Canc Ctr, Dept Med Oncol, Lyon, France | |
hcfmusp.author.external | NADAL, E.:Catalan Inst Oncol, Barcelona, Spain | |
hcfmusp.author.external | MARINIS, F. De:European Inst Oncol, IRCCS, Milan, Italy | |
hcfmusp.author.external | HAN, J-Y.:Natl Canc Ctr, Med Oncol, Goyang, South Korea | |
hcfmusp.author.external | YAN, M.:F Hoffmann La Roche, Med Oncol, Mississauga, ON, Canada | |
hcfmusp.author.external | RIEHL, T.:Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA | |
hcfmusp.author.external | SCHLEIFMAN, E.:Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA | |
hcfmusp.author.external | PAUL, S. M.:Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA | |
hcfmusp.author.external | MOCCI, S.:Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA | |
hcfmusp.author.external | SHAMES, D.:Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA | |
hcfmusp.author.external | MATHISEN, M. S.:Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA | |
hcfmusp.author.external | DZIADZIUSZKO, R.:Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland | |
hcfmusp.description.beginpage | 918 | |
hcfmusp.description.endpage | 918 | |
hcfmusp.description.issue | suppl 5 | |
hcfmusp.description.volume | 30 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.id | WOS:000491295500205 | |
hcfmusp.publisher.city | OXFORD | eng |
hcfmusp.publisher.country | ENGLAND | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.eissn | 1569-8041 | |
Appears in Collections: | Comunicações em Eventos - FM/MDR Comunicações em Eventos - HC/ICESP Comunicações em Eventos - LIM/24 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.